AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3554560 — intervention group
Group type: EXPERIMENTAL
Intervention: Forskolin 1.0% eye drops
Number of subjects: 10
Study 3554560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3554560 — intervention group
Group type: EXPERIMENTAL
Intervention: Forskolin 1% eye drops
Number of subjects: 10
Study 31310919 — intervention group
Group type: EXPERIMENTAL
Intervention: Third trimester ultrasound for screening of fetal growth restriction (FGR)
Number of subjects: 573
Study 31310919 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of third trimester ultrasound
Number of subjects: 573
Study 31310919 — intervention group
Group type: EXPERIMENTAL
Intervention: Symphysis-fundus distance measurement accuracy
Number of subjects: 573
Study 31310919 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of third trimester ultrasound on cesarean delivery rate for fetal distress
Number of subjects: 573
Study 31310919 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of routine ultrasound on admission rate to neonatal intensive care unit
Number of subjects: 573
Study 29073608 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 h of computerized, specific neuropsychological training performing simple reaction time tasks (Intervention Group, n = 14)
Number of subjects: 30
Study 29073608 — intervention group
Group type: COMPARATOR
Intervention: Computerized, unspecific neuropsychological training using tasks without time components (Control Group, n = 16)
Number of subjects: 30
Study 25847553 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation group (TFG) - received two 500mg capsules of test formulation daily for 3 months
Number of subjects: 130
Study 23361504 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-k lenses
Number of subjects: 76
Study 23361504 — intervention group
Group type: COMPARATOR
Intervention: Single-vision spectacles
Number of subjects: 76
Study 21558566 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie-expenditure (HCE) exercise (3,000-3,500 kcal/wk daily walking)
Number of subjects: 74
Study 21558566 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiac-rehabilitation (CR) exercise (700-800 kcal/wk)
Number of subjects: 74
Study 21558566 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie-expenditure (HCE) exercise
Number of subjects: 74
Study 20877184 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic hypothermia (n = 46), induced within 10 hours after birth, decreasing rectal temperature to 33.5°C for 72 hours
Number of subjects: 93
Study 20877184 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (n = 47)
Number of subjects: 93
Study 17060277 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-session, structured, multidisciplinary intervention
Number of subjects: 103
Study 17060277 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 103
Study 15342617 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan 2.5 mg oral dose
Number of subjects: 25
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosed myocardial infarction
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrecognized myocardial infarction
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosed angina
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina symptoms
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: Possible myocardial infarction symptoms
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG ischaemia
Number of subjects: 7735
Study 10843823 — intervention group
Group type: EXPERIMENTAL
Intervention: No evidence of ischaemic heart disease
Number of subjects: 7735
Study 9088589 — intervention group
Group type: EXPERIMENTAL
Intervention: GR117289C 10 mg
Number of subjects: 8
Study 9088589 — intervention group
Group type: EXPERIMENTAL
Intervention: GR117289C 100 mg
Number of subjects: 8
Study 9088589 — intervention group
Group type: EXPERIMENTAL
Intervention: GR117289C 300 mg
Number of subjects: 8
Study 9088589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8227803 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release nifedipine therapy
Number of subjects: 30
Study 8227803 — intervention group
Group type: COMPARATOR
Intervention: Placebo period
Number of subjects: 30
Study 3100446 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/kg BW carnitine daily as a continuous infusion over 16 h
Number of subjects: 24
Study 3100446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no carnitine)
Number of subjects: 24
Study 3100446 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/kg BW carnitine daily
Number of subjects: 24
Study 3259521 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy with polidocanol 1%
Number of subjects: 55
Study 3259521 — intervention group
Group type: COMPARATOR
Intervention: Oral propranolol (average daily dose 160 mg)
Number of subjects: 55
Study 3259521 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 55
Study 3259521 — intervention group
Group type: COMPARATOR
Intervention: Oral propranolol
Number of subjects: 55
Study 31805052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional meglumine antimoniate therapy (IL‐MA)
Number of subjects: 0
Study 31805052 — intervention group
Group type: COMPARATOR
Intervention: Endovenous meglumine antimoniate therapy (EV‐MA)
Number of subjects: 0
Study 27984231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycled lighting
Number of subjects: 38
Study 27984231 — intervention group
Group type: COMPARATOR
Intervention: Continuous near darkness
Number of subjects: 38
Study 25863828 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-times-weekly home nocturnal hemodialysis
Number of subjects: 87
Study 25863828 — intervention group
Group type: COMPARATOR
Intervention: 3-times-weekly hemodialysis (conventional arm)
Number of subjects: 87
Study 25863828 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month running treatment data analysis
Number of subjects: 87
Study 23436910 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-delivered acupuncture
Number of subjects: 197
Study 23436910 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-acupuncture/self-needling
Number of subjects: 197
Study 23436910 — intervention group
Group type: COMPARATOR
Intervention: No further acupuncture (control)
Number of subjects: 197
Study 21425723 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 100
Study 21425723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 19429874 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin
Number of subjects: 24
Study 19429874 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPII (Continuous Intraperitoneal Insulin Infusion)
Number of subjects: 24
Study 19429874 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPII
Number of subjects: 24
Study 16566624 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 52
Study 16566624 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 52
Study 14694037 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with T2-weighted MRI hyperintensities (T2H), n = 58
Number of subjects: 100
Study 14694037 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with normal MRI
Number of subjects: 100
Study 14694037 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with T2H
Number of subjects: 100
Study 14694037 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 100
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis only
Number of subjects: 108
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Sable seek caries detector dye
Number of subjects: 108
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine cavity cleanser
Number of subjects: 108
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries detector dye followed by prophylaxis
Number of subjects: 108
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavity cleanser followed by caries detector dye
Number of subjects: 108
Study 11314354 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoop caries detector dye
Number of subjects: 108
Study 9059294 — intervention group
Group type: COMPARATOR
Intervention: Doppler ultrasound (US)
Number of subjects: 97
Study 9059294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic contrast enhanced MRI (DCEMR)
Number of subjects: 97
Study 8403111 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (DF)
Number of subjects: 48
Study 8403111 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (IF)
Number of subjects: 48
Study 3803413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (62 +/- 18 mg/day)
Number of subjects: 43
Study 3803413 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine (128 +/- 28 mg/day)
Number of subjects: 43
Study 3803413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 43
Study 3803413 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 43
Study 30181085 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Normal Saline (NS)
Number of subjects: 30
Study 30181085 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolyte
Number of subjects: 30
Study 28514309 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) 200 U subcutaneous injection, once daily at the painful area
Number of subjects: 44
Study 28514309 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 44
Study 25464446 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 200
Study 25464446 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Continuous Training (ACT)
Number of subjects: 200
Study 24335762 — intervention group
Group type: EXPERIMENTAL
Intervention: 554 kcal mixed meal
Number of subjects: 24
Study 24335762 — intervention group
Group type: COMPARATOR
Intervention: 50 ml water
Number of subjects: 24
Study 21590446 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD)
Number of subjects: 70
Study 19774841 — intervention group
Group type: EXPERIMENTAL
Intervention: Kung Fu training
Number of subjects: 20
Study 19774841 — intervention group
Group type: COMPARATOR
Intervention: Tai Chi (placebo)
Number of subjects: 20
Study 17469765 — intervention group
Group type: EXPERIMENTAL
Intervention: 330 ml beer per day for 30 consecutive days (EG)
Number of subjects: 42
Study 17469765 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study 15206999 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol contrast medium
Number of subjects: 21
Study 15206999 — intervention group
Group type: COMPARATOR
Intervention: Control group (not taking amiodarone or QT-prolonging drugs)
Number of subjects: 21
Study 15206999 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol contrast medium with amiodarone
Number of subjects: 21
Study 12228873 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal treatments
Number of subjects: 65
Study 12228873 — intervention group
Group type: COMPARATOR
Intervention: Control (Close monitoring)
Number of subjects: 65
Study 9707042 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with ranitidine bismuth citrate (RBC) 400 mg b.i.d., clarithromycin 500 mg b.i.d., and metronidazole 500 mg b.i.d.
Number of subjects: 104
Study 9707042 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy with ranitidine bismuth citrate (RBC) 400 mg b.i.d. and clarithromycin 500 mg b.i.d.
Number of subjects: 104
Study 9707042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both triple and dual therapy
Number of subjects: 104
Study 7793859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (400 mg)
Number of subjects: 24
Study 7793859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (800 mg)
Number of subjects: 24
Study 7793859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (1,200 mg)
Number of subjects: 24
Study 7793859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (1,600 mg)
Number of subjects: 24
Study 7793859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (all doses)
Number of subjects: 24
Study 7793859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2307239 — intervention group
Group type: COMPARATOR
Intervention: FAM chemotherapy
Number of subjects: 28
Study 2307239 — intervention group
Group type: EXPERIMENTAL
Intervention: FAM chemotherapy plus aminoglutethimide/hydrocortisone (AG/HC) (250 mg bid AG + 20 mg bid HC)
Number of subjects: 28
Study 86727 — intervention group
Group type: COMPARATOR
Intervention: Outpatient care
Number of subjects: 106
Study 86727 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric day care
Number of subjects: 106
Study 31772102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 2090
Study 31772102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2090
Study 27840336 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 7875
Study 27840336 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg daily
Number of subjects: 7875
Study 25557371 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF 240 mg BID
Number of subjects: 2301
Study 25557371 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF 240 mg TID
Number of subjects: 2301
Study 25557371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2301
Study 24345717 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release (ER) (75-300 mg/d)
Number of subjects: 1047
Study 24345717 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20-60 mg/d)
Number of subjects: 1047
Study 21537042 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously every 4 weeks until the end of the last cycle)
Number of subjects: 60
Study 21537042 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (anthracycline/cyclophosphamide with or without taxane)
Number of subjects: 60
Study 21537042 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 60
Study 21537042 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 60
Study 19726376 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 19726376 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 60
Study 17711042 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (local points)
Number of subjects: 30
Study 17711042 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (distant points)
Number of subjects: 30
Study 17711042 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (local and distant points)
Number of subjects: 30
Study 17711042 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-distance acupuncture
Number of subjects: 30
Study 17711042 — intervention group
Group type: COMPARATOR
Intervention: Control (Rest Position)
Number of subjects: 30
Study 17711042 — intervention group
Group type: COMPARATOR
Intervention: Control (Bilateral Molar Clenching with Cotton Rolls)
Number of subjects: 30
Study 14756851 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac softgel 100 mg
Number of subjects: 72
Study 14756851 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac softgel 100 mg plus caffeine 100 mg
Number of subjects: 72
Study 14756851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 11478553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 40
Study 11478553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotiam
Number of subjects: 40
Study 11478553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 40
Study 11478553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/Sulbactam
Number of subjects: 40
Study 10030097 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical pharmacological treatments (diuretics and beta blockers)
Number of subjects: 0
Study 10030097 — intervention group
Group type: EXPERIMENTAL
Intervention: New drugs (calcium antagonists and angiotensin converting enzyme inhibitors)
Number of subjects: 0
Study 10030097 — intervention group
Group type: EXPERIMENTAL
Intervention: Non pharmacological therapies (sodium restriction, weight reduction, avoidance of alcohol intake, calcium and potassium supplementation)
Number of subjects: 0
Study 8047525 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 7 mg per day
Number of subjects: 0
Study 8047525 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 14 mg per day
Number of subjects: 0
Study 8047525 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 21 mg per day
Number of subjects: 0
Study 8047525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8047525 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-abstinent patients
Number of subjects: 0
Study 2647360 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post-operative radiotherapy
Number of subjects: 1461
Study 2647360 — intervention group
Group type: COMPARATOR
Intervention: Delayed radiotherapy on recurrence (watched group)
Number of subjects: 1461
Study 31311361 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma question prompt list/video intervention
Number of subjects: 359
Study 31311361 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 359
Study 31311361 — intervention group
Group type: EXPERIMENTAL
Intervention: Control medication at baseline
Number of subjects: 359
Study 30862052 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention linked to an activity monitor, adaptive physical activity goal setting, and limited face-to-face counseling
Number of subjects: 60
Study 30862052 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 28820156 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoelastic‐augmented trabeculectomy (VAT)
Number of subjects: 65
Study 28820156 — intervention group
Group type: COMPARATOR
Intervention: Conventional trabeculectomy (CT)
Number of subjects: 65
Study 26422235 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention (training clinicians in health risk screening, motivational interviewing, and engaging youth)
Number of subjects: 901
Study 26422235 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 901
Study 26422235 — intervention group
Group type: COMPARATOR
Intervention: Comparison (didactic educational seminar)
Number of subjects: 901
Study 24725024 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 44
Study 24725024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 24725024 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 44
Study 22072950 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual n-3 PUFA intake
Number of subjects: 0
Study 22072950 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipogenic transcription factors
Number of subjects: 0
Study 19371202 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0
Study 19371202 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0
Study 17011359 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioenergetic exercises (BE)
Number of subjects: 128
Study 17011359 — intervention group
Group type: COMPARATOR
Intervention: Gymnastic exercises (Control)
Number of subjects: 128
Study 15332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting of the basic and side branch of the coronary artery (Group 1, n = 27)
Number of subjects: 56
Study 15332570 — intervention group
Group type: COMPARATOR
Intervention: Stenting of the basic branch and balloon angioplasty of the side branch (Group 2, n = 29)
Number of subjects: 56
Study 11057350 — intervention group
Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% ophthalmic solution BID
Number of subjects: 0
Study 11057350 — intervention group
Group type: COMPARATOR
Intervention: Levocabastine 0.05% ophthalmic suspension BID
Number of subjects: 0
Study 9278077 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis with instrumentation and decompression
Number of subjects: 42
Study 9278077 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis with instrumentation without decompression
Number of subjects: 42
Study 9278077 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis without instrumentation and decompression
Number of subjects: 42
Study 9278077 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis without instrumentation without decompression
Number of subjects: 42
Study 7865685 — intervention group
Group type: EXPERIMENTAL
Intervention: t-PA antigen in FH patients at rest
Number of subjects: 14
Study 7865685 — intervention group
Group type: COMPARATOR
Intervention: t-PA antigen in normolipaemic controls (NLC) at rest
Number of subjects: 14
Study 7865685 — intervention group
Group type: EXPERIMENTAL
Intervention: t-PA antigen after bicycle exercise in both groups
Number of subjects: 14
Study 7865685 — intervention group
Group type: EXPERIMENTAL
Intervention: t-PA activity in FH patients during exercise
Number of subjects: 14
Study 7865685 — intervention group
Group type: COMPARATOR
Intervention: t-PA activity in NLC during exercise
Number of subjects: 14
Study 7865685 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin-antithrombin III complex (TAT) at rest and after exercise
Number of subjects: 14
Study 2669629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (2-day course)
Number of subjects: 43
Study 2669629 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (2-day course)
Number of subjects: 43
Study 401589 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate and bisacodyl
Number of subjects: 500